Insta
UP: Five Children Including A 2-Year-Old Girl Gets Covaxin Trial Jab In Kanpur
Bharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus. (Swarajya Magazine)
In a major development, a two-year-and-8-month-old girl has been administered the Covid vaccine in Kanpur Dehat during the ongoing trial of Bharat Biotech's Covaxin on children. The girl is the daughter of a doctor in Kanpur Dehat.
The spokesperson of the Prakhar hospital, where the girl was vaccinated, said on Thursday that around five children, including three girls and two boys, in the age group of 2-6 years were given the vaccine at the hospital in Kanpur.
The children were kept under observation for two hours before they were allowed to go home, said the spokesperson.
In May, the Drugs Controller General of India (DCGI) had granted permission to Bharat Biotech to commence phase 2-3 trials of Covaxin on children as young as two.
Several hospitals, including AIIMS Delhi and Patna, have also commenced the Covaxin trial on kids.
This news has been published via a Syndicated feed. Only the headline is changed.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
